Osteologix Inc. to Present at NASDAQ MarketSite During EQUITIES 2007 Transatlantic Conference
28 Sep 2007
SAN FRANCISCO--(BUSINESS WIRE)--Osteologix Inc. (OTC Bulletin Board: OLGX), a specialty pharmaceutical company developing innovative therapies for the treatment and prevention of musculoskeletal diseases, today announced that Philip J. Young, President and CEO of Osteologix, will present a corporate overview highlighting the Company’s Phase II Osteoporosis clinical trial, the STRONG Study, Friday, September 28 at 8:50 a.m. during the EQUITIES 2007 Transatlantic Conference to be held at to be held at the NASDAQ MarketSite in New York City. A live audio webcast and slide presentation will be available via the internet by visiting
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.